Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Polypoidal Choroidal Vasculopathy in Pachychoroid: Aflibercept + PDT Combined Therapy

NCT04075188 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo as lead sponsor.

NCT NCT04075188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04075188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Polypoidal Choroidal Vasculopathy in Pachychoroid: Aflibercept + PDT Combined Therapy
Lead sponsor
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Phase
Not applicable
Overall status
Completed
Start date
September 18, 2017
Completion date
July 13, 2019
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

choroid disease, choroidal neovascularization